Salarius Pharmaceuticals
$1.269876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-3.08%) As of 1:27 PM UTC pre-market
Why Robinhood?
You can buy or sell SLRX and other stocks, options, and ETFs commission-free!
About SLRX
Salarius Pharmaceuticals, Inc. Common Stock, also called Salarius Pharmaceuticals, is a clinical-stage oncology company.
CEO
David J. Arthur
Employees
9
Headquarters
Houston, Texas
Founded
2014
Market Cap
59.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
791.58K
High Today
$1.37
Low Today
$1.27
Open Price
$1.35
Volume
821.91K
52 Week High
$3.50
52 Week Low
$0.5602
SLRX Earnings
-$0.73
-$0.49
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours